UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 1) (1)
Endocare, Inc.
- ----------------------------------------------------------------------------
(Name of Issuer)
Common Stock, par value $.001 per share
- ----------------------------------------------------------------------------
(Title of Class of Securities)
29264P104
(CUSIP Number)
December 31, 1997
- ----------------------------------------------------------------------------
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this
Schedule is filed:
/x/ Rule 13d-1(b)
/ / Rule 13d-1(c)
/ / Rule 13d-1(d)
(1) The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which
would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section
of the Act but shall be subject to all other provisions of the Act (however,
see the Notes).
<PAGE>
CUSIP No. 29264P104 13G Page 2 of 6 Pages
1 NAME OF REPORTING PERSON
S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
The Kaufmann Fund, Inc.
TIN #13-2605091
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) / /
(b) / /
3 SEC USE ONLY
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Maryland
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
5 SOLE VOTING POWER
1,324.300
6 SHARED VOTING POWER
N/A
7 SOLE DISPOSITIVE POWER
1,324.300
8 SHARED DISPOSITIVE POWER
N/A
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,324.300
(Not to be construed as an admission of beneficial ownership)
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES* / /
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
15.8%
<PAGE>
12 TYPE OF REPORTING PERSON*
IV
*SEE INSTRUCTION BEFORE FILLING OUT!
<PAGE>
Item 1(a) Name of Issuer:
--------------
Endocare, Inc.
Item 1(b) Address of Issuer's Principal Executive Offices:
-----------------------------------------------
7 Studebaker
Irvine, California 92618
Item 2(a) Name of Persons Filing:
----------------------
The Kaufmann Fund, Inc.
Item 2(b) Address of Principal Business Office or, if none,
Residence:
-------------------------------------------------
140 East 45th Street, 43rd Floor
New York, New York 10017
Item 2(c) Citizenship:
-----------
The Kaufmann Fund, Inc. is incorporated under the
laws of Maryland.
Item 2(d) Title of Class of Securities:
----------------------------
Common Stock, par value $.001 per share
Item 2(e) CUSIP No.:
---------
29264P104
Item 3 If this statement is filed pursuant to Rules 13d-
1(b), or 13d-2(b), check whether the person filing is a:
--------------------------------------------------
(a) / / Broker or dealer registered under Section
15 of the Exchange Act.
(b) / / Bank as defined in Section 3(a)(6) of the
Exchange Act.
(c) / / Insurance company as defined in Section
3(a)(19) of the Exchange Act.
(d) /x/ Investment company registered under
Section 8 of the Investment Company Act.
<PAGE>
(e) / / An investment adviser in accordance with
Rule 13d-1(b)(1)(ii)(E);
(f) / / An employee benefit plan or endowment
fund in accordance with Rule 13d-
1(b)(1)(ii)(F);
(g) / / A parent holding company or control
person in accordance with Rule 13d-
1(b)(1)(ii)(G);
(h) / / A savings association as defined in
Section 3(b) of the Federal Deposit
Insurance Act;
(i) / / A church plan that is excluded from the
definition of an investment company under
Section 3(c)(14) of the Investment
Company Act;
(j) / / Group, in accordance with Rule 13d-
1(b)(1)(ii)(J).
If this statement is filed pursuant to Rule 13d-
1(c), check this box. / /
Item 4 Ownership:
---------
(a) Amount Beneficially Owned:
1,324.300 shares
(b) Percent of Class:
15.8%
(c) Number of shares as to which such person has:
(i) Sole power to vote or to direct the vote:
1,324.300 shares
(ii) Shared power to vote or to direct the vote:
N/A
(iii) Sole power to dispose or to direct the
disposition of:
1,324.300 shares
<PAGE>
(iv) Shared power to dispose or to direct the
disposition of:
N/A
Item 5 Ownership of Five Percent or Less of a Class:
--------------------------------------------
If this statement is being filed to report the fact
that as of the date hereof the reporting person has
ceased to be the beneficial owner of more than five
percent of the class of securities, check the
following: / /
Item 6 Ownership of More Than Five Percent on Behalf of
Another Person:
------------------------------------------------
Not applicable
Item 7 Identification and Classification of the Subsidiary
Which Acquired the Security Being Reported on By the
Parent Holding Company:
Not applicable
Item 8 Identification and Classification of Members of the
Group:
---------------------------------------------------
Not applicable
Item 9 Notice of Dissolution of Group:
------------------------------
Not applicable
Item 10 Certification:
-------------
By signing below I certify that, to the best of my
knowledge and belief, the securities referred to
above were acquired and are held in the ordinary
course of business and were not acquired and are not
held for the purpose of or with the effect of
<PAGE>
changing or influencing the control of the issuer of
the securities and were not acquired and are not
held in connection with or as a participant in any
transaction having that purpose or effect.
<PAGE>
SIGNATURE
---------
After reasonable inquiry and to the best of my knowledge and belief,
I certify that the information set forth in this statement is true, complete
and correct.
Date: April 27, 1998
THE KAUFMANN FUND, INC.
/s/ ANTHONY W. TOOGOOD
----------------------
Title: Vice-President
